Nina Delaney Wagner-Johnston, M.D.

  • Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Professor of Oncology


Chemotherapy Induced Peripheral Neuropathy, Hodgkin's Disease, Medical Oncology, Non-Hodgkin's Lymphoma (NHL), Palliative Care more

Research Interests

Lymphoma; AIDS-related malignancies; palliative/supportive care; chemotherapy induced peripheral neuropathy; CIPN more


Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

401 N. Broadway
Baltimore, MD 21231 map


Dr. Nina Wagner-Johnston is Associate Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University.

Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015.

Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri.

Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy.  

Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine.  She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. more


  • Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Co-Director of Clinical Research for Hematologic Malignancies
  • Professor of Oncology

Departments / Divisions

Centers & Institutes



  • MD; University of Chicago Pritzker School of Medicine (2003)


  • Internal Medicine; University of Chicago Medicine Mitchell Hospital-Hyde Park (2005)


  • Oncology; Johns Hopkins University School of Medicine (2008)

Research & Publications

Selected Publications

View all on PubMed

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, Friedberg JW, Bartlett NL. Blood. 2015 Aug 13;126(7):851-7. doi: 10.1182/blood-2015-01-621375. Epub 2015 Jun 23. PMID: 26105149

Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL; American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. Review. PubMed PMID: 24733808.

Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. Cancer. 2014 Jul 15;120(14):2122-9. doi: 10.1002/cncr.28698.  Epub 2014 Apr 7. PubMed PMID: 24711253.


Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A, Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA. PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med. 2014 Mar 13;370(11):1008-18. doi: 10.1056/NEJMoa1314583.  Epub 2014 Jan 22. PubMed PMID: 24450858; PubMed Central PMCID: PMC4039496.

Wagner-Johnston ND, Gellert L, Gocke CD, Lemas VM, Lee J, Martínez-Maza O, Ambinder RF. Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma. Blood. 2011 May 5;117(18):4860-2. doi: 10.1182/blood-2010-12-324657. Epub 2011 Mar 9. PubMed PMID: 21389324; PubMed Central PMCID: PMC3100695.

Activities & Honors


  • Sigma Theta Tau International Honor Society, 1993 - 1994
  • Commencement Speaker, Georgetown University School of Nursing, 1994
  • Calvin Fentress Research Fellowship Award, 2002
  • Young Investigator Award, Supportive Oncology Conference, 2008
  • Mentoring Program Award, American Academy of Hospice and Palliative Medicine, 2012
  • Sidney Kimmel Director's Teaching Award in Clinical Science, 2015 - 2016


  • American Society of Hematology, 2007
  • American Society of Clinical Oncology, 2007
  • NCCN Palliative Care

    Panel Member

  • ALLIANCE for Clinical Trials in Oncology (formerly CALGB), 2008 - 2015

    Lymphoma and Symptom Intervention Committees

  • AIDS Malignancies Consortium (AMC), 2008


  • NCCN Cancer-related Fatigue, 2011

    Panel Member

  • American Academy of Hospice and Palliative Medicine (AAHPM), 2012 - 2014
  • Palliative Care Research Cooperative Group (PCRC), 2012

    Scientific Review Committee Co-Chair

  • ASCO Neuropathy Guidelines Panel, 2013


  • NCI Lymphoma Steering Committee Clinical Trials Design Committee, 2014 - 2015

    Junior Faculty Member

  • NCI Symptom Management and Health-Related Quality of Life Steering Committee, 2014 - 2015


Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button